OIRA and the Future of Cost-Benefit Analysis
The Trump Administration’s dismissiveness toward regulatory analysis reveals a need for institutional reform.
Celebrating Our 2019-2020 Editorial Board
Thank you and congratulations to our 2019-2020 Editorial Board.
The Disjointed Dutch Policies to Fight COVID-19
The Dutch need to coordinate their different regulatory and behavioral responses to tackle COVID-19.
Trump’s Flawed Rollback of Fuel Economy Rules
Recent regulatory retreat over automobile fuel efficiency undermines both climate progress and U.S. competitiveness.
Telemedicine During the COVID-19 Crisis
With medical systems overwhelmed during the pandemic, telemedicine could be here to stay.
Week in Review
The Supreme Court reviews Congress’s subpoena power, California guarantees mail-in ballots for the general election, and more…
South Korea’s Success Against COVID-19
Transparency, communication, and collaboration are the key weapons in the fight against COVID-19.
Public Health Versus Privacy
Efforts to trace the novel coronavirus in the U.S. ignite a debate over digital privacy concerns.
Federal Focus Shifts to COVID-19 Treatments
FDA releases guidance on using blood from recovered COVID-19 patients to treat new cases.
COVID-19 and Cooperative Administrative Federalism in Germany
Germany’s response to COVID-19 consists of federal delegation, state regulation, and multi-level cooperation.
Learning in the Age of Social Distancing
An Education Department proposal paves the way for a new normal in online instruction.
Continuous Judicial Review in Coronavirus Times
The Israeli judiciary exerts oversight and influence over the executive’s COVID-19 response.